Table 1 Baseline clinical, echocardiographic and procedural characteristics
RF group (n = 90) | CB group (n = 64) | p value | |
|---|---|---|---|
Age, year | 62.7 ± 10.0 | 60.8 ± 8.9 | 0.23 |
Female Gender | 32% | 27% | 0.45 |
Mean BMI, kg/m2 | 27.9 ± 4.2 | 26.8 ± 3.4 | 0.07 |
AF duration, year | 5.8 ± 5.0 | 5.4 ± 4.2 | 0.82 |
Comorbidities | |||
Hypertension | 44% | 36% | 0.29 |
Diabetes mellitus | 17% | 11% | 0.32 |
Coronary artery disease | 9% | 9% | 0.92 |
Heart Failure | 4% | 5% | 0.94 |
Stroke | 6% | 9% | 0.37 |
Echocardiographic parameters | |||
LA diameter, mm | 43.5 ± 5.0 | 42.5 ± 4.1 | 0.19 |
LVEF, % | 61.6 ± 9.0 | 63.8 ± 6.0 | 0.09 |
Procedure details | |||
Procedure duration, min | 125.0 ± 29.5 | 110.0 ± 23.7 | 0.001 |
Fluoroscopy duration, min | 16.7 ± 6.0 | 16.9 ± 6.2 | 0.24 |